Comprehensive analysis to identify PUS7 as a prognostic biomarker from pan-cancer analysis to osteosarcoma validation
Aging · 2024
DOI: 10.18632/aging.205863 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Baokang Dong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Tianjin First Central Hospital, Nankai University, Tianjin 300192, China. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Osteosarcoma, Intramolecular Transferases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, Tianjin First Central Hospital, Nankai University, Tianjin 300192, China.
- Department of Bone Tumor and Soft Tissue Oncology, Tianjin Hospital of Tianjin University, Tianjin 300211, China.
- Department of Pathology, Tianjin Hospital of Tianjin University, Tianjin 300211, China.
Zitieren
APA
Dong, B., Wang, B., Fan, M., Zhang, J., & Zhao, Z. (2024). Comprehensive analysis to identify PUS7 as a prognostic biomarker from pan-cancer analysis to osteosarcoma validation. Aging. https://doi.org/10.18632/aging.205863
Vancouver
Dong B, Wang B, Fan M, Zhang J, Zhao Z. Comprehensive analysis to identify PUS7 as a prognostic biomarker from pan-cancer analysis to osteosarcoma validation. Aging. 2024. doi:10.18632/aging.205863
BibTeX
@article{Dong2024,
author = {Dong, Baokang and Wang, Binqi and Fan, Meng and Zhang, Jingyu and Zhao, Ziqin},
title = {Comprehensive analysis to identify PUS7 as a prognostic biomarker from pan-cancer analysis to osteosarcoma validation},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.205863}
}
EUVIMED